期刊文献+

早期短期小剂量糖皮质激素联合阿奇霉素治疗儿童支原体肺炎的疗效分析 被引量:9

Efficacy analysis of early short-term low-dose glucocorticoid combined with azithromycin in curing mycoplasma pneumonia in children
下载PDF
导出
摘要 目的探讨分析短期小剂量糖皮质激素联合阿奇霉素治疗儿童支原体肺炎的临床效果。方法选取2012年1月至2013年6月住院治疗的支原体肺炎患儿120例,分为治疗组和对照组,各60例,治疗组予阿奇霉素联合甲泼尼龙治疗,对照组予阿奇霉素联合安慰剂治疗。对比两组间发热持续时间、咳嗽缓解时间,对比治疗前后外周血白细胞数、超敏C反应蛋白(CRP)、胸片的变化,评估疗效。结果治疗组发热时间缩短,咳嗽缓解时间提前,外周血白细胞数、超敏C反应蛋白下降幅度更为明显,胸片改善病例数多于对照组。两组患儿的退热时间、咳嗽缓解时间、外周血白细胞数、超敏C反应蛋白下降程度、胸片改善例数的差异均有统计学意义(P<0.05)。结论早期短期小剂量使用糖皮质激素联合治疗儿童支原体肺炎,疗效更明显。 Objective To explore and analyze the clinical effect of short- term low- dose glucocorticoid combined with azithromycin for the treatment of children mycoplasma pneumonia. Methods Select 120 children with mycoplasma pneumonia hospitalized during January 2012 and June 2013,they were divided into treatment group and control group,60 cases for each group. Patients in treatment group received azithromycin plus methylprednisolone for therapy and the control group was given azithromycin combined with placebo. Compare the duration of fever,cough relief time of the two groups,compared peripheral blood leucocyte count,high-sensitivity C- reactive protein( CRP) and chest X- ray changes before and after treatment,and assessed the efficacy. Results The fever duration of treatment group shortened,cough ease ahead of time,peripheral blood leucocyte countand high- sensitivity C- reactive protein has more pronounced decrease. The number of improved chest X- ray cases was more than the control group. The differences of cooling time,cough relief time,peripheral blood leucocyte count,the degree of high- sensitivity C- reactive protein decrease,the number of improved chest X- ray cases of the two groups' children were statistically significant( P〈0. 05). Conclusions Early use of short- term low- dose glucocorticoid combined with azithromycin in the treatment of mycoplasma pneumonia in children could have more obvious curative effect.
出处 《齐齐哈尔医学院学报》 2015年第1期41-43,共3页 Journal of Qiqihar Medical University
关键词 糖皮质激素 支原体肺炎 儿童 治疗 Cortical hormone Mycoplasma pneumonia Children Therapy
  • 相关文献

参考文献11

  • 1陈志敏.儿童肺炎支原体感染诊治研究进展[J].临床儿科杂志,2008,26(7):562-565. 被引量:150
  • 2Gaillat J, Flahault A, deBarbeyrae B, et al. Community epidemiology of Chlamydia and Mycoplasma Pneumoniae in LRTI in France over 29months[ J]. Eur J Epidemiol,2005,20 ( 7 ) :643- 651.
  • 3Bamha M, Jozaki K, Sugaya N, Tamai S, Ishihara J, Kori T, et al. Prospective surveillance for atypical pathogens in children with community - acquired pneumonia in Japan [ J ]. J Infect Chemother,2006,12:36-41.
  • 4Waites KB ,Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen [ J ]. Clin Microbiol Rev, 2004, 17 ( 4 ) : 697- 728.
  • 5Tanaka H,Narita M,Teramoto et al. Role of interleukin -18 and T - helpor type I cytokines in the development of mycoplasma pneuminiae in adults[ J]. Chest,2002,121 (5) : 1493.
  • 6高惠,罗征秀,罗健,徐秀娟,刘恩梅,符州.儿童肺炎支原体肺炎后遗症临床危险因素分析[J].重庆医科大学学报,2013,38(2):165-167. 被引量:27
  • 7董宗祈.肺炎支原体感染的致病机制与治疗的关系[J].实用儿科临床杂志,2007,22(4):243-245. 被引量:228
  • 8Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe mycoplasma pneumonia pneumonia in children [ J ]. Pediatr Pulmono1,2006,41 ( 3 ) :263-268.
  • 9Akihiro T, Kousaku M,Takayuki T, et al. Methylprednisolone pulse therapy for refractory mycoplasma pneumoniae pneumonia in children [ J]. Journal of Infection,2008,57 (3) :223-228.
  • 10Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community - acquired pneumonia: a randomised, double - blind, placebo - controlled trial [ J ]. Lancet,2011,377 (9782) :2023-2030.

二级参考文献46

  • 1徐红贞,陈志敏.2001~2002年冬夏季杭州地区小儿肺炎非细菌多病原学研究[J].临床儿科杂志,2004,22(9):610-612. 被引量:7
  • 2江澜,刘传合,赵顺英.2005年全国小儿社区获得性呼吸道感染专题研讨会纪要[J].中华儿科杂志,2005,43(11):876-877. 被引量:25
  • 3赵顺英.儿童呼吸系统疾病的临床研究进展[J].中国实用儿科杂志,2007,22(5):347-348. 被引量:34
  • 4胡亚美 江载芳.实用儿科学(下册)[M]7版[M].北京:人民卫生出版社,2002.1537.
  • 5Zhanel GG,Duecle M,Hoban DJ,et al.Review of macrolides and keto-lides:Focus on respiratory tract infections[J].Drugs,2001,61(4):443-498.
  • 6Waites KB ,Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen [J]. Clin Microbiol Rev, 2004,17(4) :697-728.
  • 7Vervloet LA, Marguet C, Camargos PA. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumo- nias [J]. Braz J Infect Dis,2007,11(5):507-514.
  • 8Chiang WC, Teoh OH, Chong CY, et al. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore [J]. Respirology,2007,12 (2) : 254-261.
  • 9Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae:serological results of a prospective,population-based study in primary health care [J ]. Respirology, 2004,9 ( 1 ) : 109-114.
  • 10Ngeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia [J]. Int J Infect Dis,2005,9(3) : 144-153.

共引文献398

同被引文献64

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部